Table 3.
Intra- and intergroup comparisons of HR, SBP, DBP, and MABP among the 3 drug groups
| Variable | Times (mean±SD) | P* | |||
|---|---|---|---|---|---|
|
| |||||
| Baseline | Intubation | After 1 min | After 5 min | ||
| HR (bpm) | 0.065 | ||||
| Propofol | 78.89±17.00 | 71.00±14.01 | 70.81±15.29 | 68.28±15.41 | |
| Etomidate | 84.09±13.89 | 71.33±13.81 | 74.39±14.69 | 67.59±10.52 | |
| Midazolam | 87.1±16.1 | 68.92±12.54 | 73.81±16.2 | 66.11±15.20 | |
| P* | 0.688 | ||||
| SBP (mm Hg) | <0.001 | ||||
| Propofol | 147.91±25.90 | 105.04±24.91 | 99.11±20.52 | 103.49±2139 | |
| Etomidate | 148.47±29.21 | 118.73±25.01 | 133.22±39.01 | 126.81±27.00 | |
| Midazolam | 151.22±29.89 | 109.41±24.42 | 122.92±24.36 | 103.81±18.74 | |
| P* | <0.001 | ||||
| DBP (mm Hg) | <0.001 | ||||
| Propofol | 69.81±10.81 | 56.46±17.80 | 54.71±13.91 | 55.42±13.89 | |
| Etomidate | 63.29±13.62 | 54.42±12.31 | 64.49±17.00 | 62.71±14.70 | |
| Midazolam | 61.90±14.17 | 50.81±12.60 | 60.01±14.77 | 48.91±11.20 | |
| P ** | 0.056 | ||||
| MABP (mm Hg) | <0.001 | ||||
| Propofol | 99.41±13.21 | 72.56±19.00 | 70.53±16.22 | 73.04±16.78 | |
| Etomidate | 93.46±17.80 | 77.51±15.19 | 90.22±26.19 | 83.79±17.50 | |
| Midazolam | 95.22±18.19 | 70.08±13.91 | 80.11±16.68 | 67.68±13.51 | |
| P ** | <0.001 | ||||
*Intergroup, multivariate analysis of the repeated measures test
**Intragroup, analysis of the variances test
SBP, Systolic blood pressure; DBP, Diastolic blood pressure; HR, Heart rate; MABP, Mean arterial blood pressure